Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Return on Assets (2018 - 2022)

Historic Return on Assets for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to 0.59%.

  • Iterum Therapeutics' Return on Assets rose 3800.0% to 0.59% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.59%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 1.47% for FY2021, which is 3300.0% up from last year.
  • Latest data reveals that Iterum Therapeutics reported Return on Assets of 0.59% as of Q3 2022, which was up 3800.0% from 0.13% recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Return on Assets registered a high of 0.04% during Q1 2022, and its lowest value of 2.91% during Q1 2020.
  • Over the past 5 years, Iterum Therapeutics' median Return on Assets value was 1.04% (recorded in 2021), while the average stood at 1.32%.
  • As far as peak fluctuations go, Iterum Therapeutics' Return on Assets crashed by -20000bps in 2020, and later surged by 18800bps in 2022.
  • Over the past 5 years, Iterum Therapeutics' Return on Assets (Quarter) stood at 0.72% in 2018, then plummeted by -277bps to 2.7% in 2019, then surged by 34bps to 1.78% in 2020, then surged by 46bps to 0.96% in 2021, then soared by 39bps to 0.59% in 2022.
  • Its Return on Assets stands at 0.59% for Q3 2022, versus 0.13% for Q2 2022 and 0.04% for Q1 2022.